Marc Funk

Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland.

Chime Biologics Ltd. is a leading Contract Development and Manufacturing Organization (CDMO) that provides customer-centric and cost-effective outsourcing services for biopharmaceutical development and manufacturing. The company is based in Wuhan, China, and its world's first GE Kubio facility is located at Wuhan's Bio-Lake Biotech Industry Development Zone, with a clear path to expand the total capacity up to 140,000+ liters in the near future. The Chinese company has introduced the world's first modular biopharmaceutical plant, Kubio, which empowers its partners' success in biologics from cell line development to commercial manufacturing. Chime Biologics is committed to making cutting-edge biomedicines affordable and accessible to all patients, fulfilling its commitment to human health. Chime Biologics is ISO 14001:2015 and ISO 45001:2018 certified and has been providing customers with clinical materials for pre-clinical and clinical stages worldwide since 2016.

Recipharm AB engages in the manufacture of pharmaceuticals and contract development services for pharmaceutical companies. It operates through the following segments: Manufacturing Sterile and Inhalation (MFG-SI); Manufacturing Solids and Others (MFG-SO); Development and Technology (D&T); and Others and Eliminations. The MFG-SI segment includes manufacturing of products on behalf of pharmaceutical companies and covers sterile and inhalation technologies as well as liquid vials and ampoules, lyophilisates, blow-fill-seal products, and inhalation. The MFG-SO segment produces products on behalf of pharmaceutical companies and covers tablets, capsules, semi-solids, and non-sterile liquids. The D&T segment focuses on pharmaceutical development services. The company was founded by Lars Rickard Backsell and Thomas Bengt Eldered in 1995 and is headquartered in Stockholm, Sweden.

Bionter AG is a start-up that specializes in providing particle counters for the pharmaceutical and biotechnology industries. The company is based in Riehen, Switzerland, and Tobias Werk has been the CEO since 2020. The Swiss company is dedicated to revolutionizing the industry with innovative breakthrough developments that increase quality, safety, and cost-effectiveness.